Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription Articles published in Pathology Retrieve available abstracts of 10 articles: HTML format

Single Articles

June 2025
1. BAEZ-NAVARRO X, Groenendijk FH, Oudijk L, von der Thusen J, et al
   HER2-low across solid tumours: different incidences and definitions.
   Pathology. 2025;57:403-414.
   PubMed     Abstract available
   
   
   February 2025
2. ZAWATI I, Troujette Y, Adouni O, Manai M, et al
   Can residual proliferative cancer burden predict long-term outcomes following neoadjuvant chemotherapy in breast cancer?
   Pathology. 2025 Feb 12:S0031-3025(25)00063-7. doi: 10.1016/j.pathol.2024.
   PubMed     Abstract available
   
   
   November 2024
3. KARIRI YA, Alsaleem M, Al-Kawaz A, Alhatlani BY, et al
   Cell division cycle 6 ?is an independent prognostic biomarker in breast cancer.
   Pathology. 2024 Nov 14:S0031-3025(24)00294-0. doi: 10.1016/j.pathol.2024.
   PubMed     Abstract available
   
   
   October 2024
4. FARSHID G, Ibbetson SJ, Pradhan M, Henry L, et al
   Clinical, histological and receptor profiles of invasive breast cancer and ductal carcinoma in situ in females with germline pathogenic variants in PTEN and implications for germline testing.
   Pathology. 2024 Oct 15:S0031-3025(24)00245-9. doi: 10.1016/j.pathol.2024.
   PubMed     Abstract available
   
   
   
5. LEE DHY, Tsang JY, Li JJX, Lau SL, et al
   Cytokeratin 15 is a novel and independent predictor of poor outcome in luminal B HER2-negative breast carcinomas.
   Pathology. 2024;56:834-841.
   PubMed     Abstract available
   
   
   June 2024
6. LASHEN AG, Almalki N, Toss M, Mirza S, et al
   The characteristics and prognostic significance of histone H1 expression in breast cancer.
   Pathology. 2024 Jun 8:S0031-3025(24)00143-0. doi: 10.1016/j.pathol.2024.
   PubMed     Abstract available
   
   
   April 2024
7. LAMI K, Yoon HS, Parwani AV, Pham HHN, et al
   Validation of prostate and breast cancer detection artificial intelligence algorithms for accurate histopathological diagnosis and grading: a retrospective study with a Japanese cohort.
   Pathology. 2024 Apr 19:S0031-3025(24)00101-6. doi: 10.1016/j.pathol.2024.
   PubMed     Abstract available
   
   
   
8. ZENGIN HB, Tan PH, Liu R, Smoller BR, et al
   'Eczematous' dermatitis of the nipple: clinical and histopathological differential diagnosis of Paget disease.
   Pathology. 2024;56:300-312.
   PubMed     Abstract available
   
   
   
9. TAY TKY, Tan GS, Lee SH, Sam XX, et al
   Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers.
   Pathology. 2024;56:325-333.
   PubMed     Abstract available
   
   
   March 2024
10. WU Y, Chen F, Pan L, Chao X, et al
    Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Pathology. 2024 Mar 14:S0031-3025(24)00084-9. doi: 10.1016/j.pathol.2024.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.